Stock LTRN LANTERN PHARMA INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Lantern Pharma Inc.

Equities

LTRN

US51654W1018

Market Closed - Nasdaq
Other stock markets
 01:30:00 02/07/2024 am IST 		5-day change 1st Jan Change
4.52 USD -3.21% Intraday chart for Lantern Pharma Inc. +15.60% +5.61%
12/06 Lantern Pharma Secures Composition of Matter Patent for LP-284 in Japan MT
12/06 Lantern Pharma Inc. Receives Certificate of Patent from Japanese Patent Office for Composition of Matter Covering Drug Candidate LP-284 CI

Evolution of the average Target Price on Lantern Pharma Inc.

Price target over the last 5 years

History of analyst recommendation changes

5f4c735.psyYZy941XPIY7T-NtTzQ8zGDQnQvhRqhtchSj7TcbA.3IvyBEI3gRGJJeCzVba_D6CqO2aBxFgd0OBCfwyeSInqu_pXYTKTBvkwxw~1e78bbe3f9ab8ba0df6f917641abab9c

Analyst Recommendations on Lantern Pharma Inc.

HC Wainwright Starts Lantern Pharma at Neutral MT
EF Hutton Starts Lantern Pharma at Buy With $11 Price Target MT
HC Wainwright Adjusts Lantern Pharma's Price Target to $36 From $34, Reiterates Buy Rating MT
HC Wainwright Adjusts Lantern Pharma's Price Target to $34 From $32, Keeps Buy Rating MT
LANTERN PHARMA : HC Wainwright Starts Lantern Pharma at Buy with $32 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
4.52 USD
Average target price
22 USD
Spread / Average Target
+386.73%
High Price Target
26 USD
Spread / Highest target
+475.22%
Low Price Target
18 USD
Spread / Lowest Target
+298.23%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Lantern Pharma Inc.

HC Wainwright
EF Hutton

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. LTRN Stock
  4. Consensus Lantern Pharma Inc.